BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 11274056)

  • 41. Role of MBD2 in gene regulation and tumorigenesis.
    Berger J; Bird A
    Biochem Soc Trans; 2005 Dec; 33(Pt 6):1537-40. PubMed ID: 16246164
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Methyl-CpG-binding proteins. Targeting specific gene repression.
    Ballestar E; Wolffe AP
    Eur J Biochem; 2001 Jan; 268(1):1-6. PubMed ID: 11121095
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multiple binding of methyl-CpG and polycomb proteins in long-term gene silencing events.
    Matarazzo MR; De Bonis ML; Strazzullo M; Cerase A; Ferraro M; Vastarelli P; Ballestar E; Esteller M; Kudo S; D'Esposito M
    J Cell Physiol; 2007 Mar; 210(3):711-9. PubMed ID: 17133344
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation.
    Zhang Y; Ng HH; Erdjument-Bromage H; Tempst P; Bird A; Reinberg D
    Genes Dev; 1999 Aug; 13(15):1924-35. PubMed ID: 10444591
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
    Pulukuri SM; Rao JS
    Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The barrier function of an insulator couples high histone acetylation levels with specific protection of promoter DNA from methylation.
    Mutskov VJ; Farrell CM; Wade PA; Wolffe AP; Felsenfeld G
    Genes Dev; 2002 Jun; 16(12):1540-54. PubMed ID: 12080092
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An intrinsically disordered region of methyl-CpG binding domain protein 2 (MBD2) recruits the histone deacetylase core of the NuRD complex.
    Desai MA; Webb HD; Sinanan LM; Scarsdale JN; Walavalkar NM; Ginder GD; Williams DC
    Nucleic Acids Res; 2015 Mar; 43(6):3100-13. PubMed ID: 25753662
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Drosophila MBD family member is a transcriptional corepressor associated with specific genes.
    Ballestar E; Pile LA; Wassarman DA; Wolffe AP; Wade PA
    Eur J Biochem; 2001 Oct; 268(20):5397-406. PubMed ID: 11606202
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Methyl-CpG binding protein MBD2 is implicated in methylation-mediated suppression of miR-373 in hilar cholangiocarcinoma.
    Chen Y; Gao W; Luo J; Tian R; Sun H; Zou S
    Oncol Rep; 2011 Feb; 25(2):443-51. PubMed ID: 21165562
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preferential binding of the methyl-CpG binding domain protein 2 at methylated transcriptional start site regions.
    Chatagnon A; Perriaud L; Nazaret N; Croze S; Benhattar J; Lachuer J; Dante R
    Epigenetics; 2011 Nov; 6(11):1295-307. PubMed ID: 22048253
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CpG and methylation-dependent DNA binding and dynamics of the methylcytosine binding domain 2 protein at the single-molecule level.
    Pan H; Bilinovich SM; Kaur P; Riehn R; Wang H; Williams DC
    Nucleic Acids Res; 2017 Sep; 45(15):9164-9177. PubMed ID: 28637186
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Drosophila methyl-DNA binding protein MBD2/3 interacts with the NuRD complex via p55 and MI-2.
    Marhold J; Brehm A; Kramer K
    BMC Mol Biol; 2004 Oct; 5(1):20. PubMed ID: 15516265
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TACC3 mediates the association of MBD2 with histone acetyltransferases and relieves transcriptional repression of methylated promoters.
    Angrisano T; Lembo F; Pero R; Natale F; Fusco A; Avvedimento VE; Bruni CB; Chiariotti L
    Nucleic Acids Res; 2006; 34(1):364-72. PubMed ID: 16410616
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impaired memory CD8 T cell development in the absence of methyl-CpG-binding domain protein 2.
    Kersh EN
    J Immunol; 2006 Sep; 177(6):3821-6. PubMed ID: 16951344
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MBD3 mediates epigenetic regulation on EPAS1 promoter in cancer.
    Cui J; Duan B; Zhao X; Chen Y; Sun S; Deng W; Zhang Y; Du J; Chen Y; Gu L
    Tumour Biol; 2016 Oct; 37(10):13455-13467. PubMed ID: 27465550
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MBD2 upregulates miR-301a-5p to induce kidney cell apoptosis during vancomycin-induced AKI.
    Wang J; Li H; Qiu S; Dong Z; Xiang X; Zhang D
    Cell Death Dis; 2017 Oct; 8(10):e3120. PubMed ID: 29022913
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Control of the DNA methylation system component MBD2 by protein arginine methylation.
    Tan CP; Nakielny S
    Mol Cell Biol; 2006 Oct; 26(19):7224-35. PubMed ID: 16980624
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mbd2 promotes foxp3 demethylation and T-regulatory-cell function.
    Wang L; Liu Y; Han R; Beier UH; Thomas RM; Wells AD; Hancock WW
    Mol Cell Biol; 2013 Oct; 33(20):4106-15. PubMed ID: 23979593
    [TBL] [Abstract][Full Text] [Related]  

  • 59. p66Alpha-MBD2 coiled-coil interaction and recruitment of Mi-2 are critical for globin gene silencing by the MBD2-NuRD complex.
    Gnanapragasam MN; Scarsdale JN; Amaya ML; Webb HD; Desai MA; Walavalkar NM; Wang SZ; Zu Zhu S; Ginder GD; Williams DC
    Proc Natl Acad Sci U S A; 2011 May; 108(18):7487-92. PubMed ID: 21490301
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transcription onset of genes critical in liver carcinogenesis is epigenetically regulated by methylated DNA-binding protein MBD2.
    Stefanska B; Suderman M; Machnes Z; Bhattacharyya B; Hallett M; Szyf M
    Carcinogenesis; 2013 Dec; 34(12):2738-49. PubMed ID: 23955541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.